STAT

APRIL 30, 2024

Eli Lilly raised its full-year guidance on Tuesday while it reported strong first-quarter sales of Zepbound, even as the pharmaceutical company struggles to make enough of the obesity drug to meet the enormous demand. Lilly increased its adjusted earnings guidance for 2024 to a range of $13.50 per share, beating the $2.39

Pharmaceutical Companies 132

Pharmaceutical Companies Pharmaceutical Companies 132

STAT

OCTOBER 24, 2023

Following two decades of sharp increases for consumers, the companies vowed to cut insulin prices for some insulins by at least 70%, meaning many people could see their insulin costs capped at $35 a month in the near future. Sanofi and NovoNordisk will lower their prices as of January 2024; Lilly reduced it to $35 per month in March 2023.)

Pharmaceutical Companies 135

Pharmaceutical Companies Pharmaceutical Companies 135

STAT

MARCH 18, 2024

The biggest enticement that large pharmacy benefit managers offer to the employers that hire them is drug rebates — a steady stream of money sent back to their clients, a tangible symbol of the discounts that PBMs are able to wrangle out of pharmaceutical companies. Continue to STAT+ to read the full story…

Documentation 145

Documentation Pharmaceutical Companies Pharmaceutical Companies Insurance 145

STAT

OCTOBER 17, 2024

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. You

Pharmaceutical Companies 135

Pharmaceutical Companies Pharmaceutical Companies FDA 135

STAT

MAY 22, 2024

A 2024 analysis of drugs included in this program showed they had 23% shorter clinical development timelines than those that were not part of the program, with no negative effects on their safety profiles.

Pharmaceutical Companies 120

Pharmaceutical Companies Pharmaceutical Companies 120

STAT

OCTOBER 18, 2024

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. You

Pharmaceutical Companies 107

Pharmaceutical Companies Pharmaceutical Companies 107

European Pharmaceutical Review

MARCH 27, 2025

As scientific and pharmaceutical companies grapple to secure the worlds best talent, the science and immigration sectors are aware that the UKs ability to attract global talent in science and technology is constantly under question. Summary of visa costs analysis 2024. How do the UKs immigration costs compare? References 1.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling 52

Pharmafile

MARCH 17, 2023

French pharmaceutical company Sanofi has announced that it will cut the list price of its Lantus (insulin glargine injection) 100 units/ml by 78%, beginning January 2024. read more

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Insurance 59

InCrowd

APRIL 30, 2024

ASCO 2024, a pivotal conference for unveiling the latest advancements in cancer care, is just around the corner and oncologists are ready for it. Attendance Outlook: An impressive 72% of oncologists, whether attending in-person or virtually, are gearing up for ASCO 2024, underscoring the event’s importance in the oncology community.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

NOVEMBER 25, 2024

percent between 2024 and 2032. An increasing trend of outsourcing boosts growth of the market as pharmaceutical companies are utilising advanced testing capabilities and optimising their drug development processes. percent market share between 2024 and 2032, based on the forecast by Straits Research. billion by 2032.

Compounding 52

Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Hospital Pharmacy Europe

DECEMBER 5, 2024

2024 was a transformative year in pharmacy and therapeutics, marked by groundbreaking advances that promise lasting impacts on healthcare. Dr João Gonçalves PhD presents his pick for this year’s top five pharmacy innovations, illustrating how they set new standards for patient care and pharmaceutical development.

Vaccines 59

Vaccines Patient Care Compounding Pharmaceutical Companies 59

The Guardian - Pharmaceutical Industry

APRIL 11, 2024

pay boost Shareholders at AstraZeneca are in line for a 7% increase in dividends this year as the pharmaceutical company attempts to garner support for a pay deal worth up to £19m for its boss, Pascal Soriot. AstraZeneca said it intended to increase the annual dividend for 2024 by $0.20

Pharmaceutical Companies 79

Pharmaceutical Companies Pharmaceutical Companies 79

European Pharmaceutical Review

AUGUST 3, 2023

EPC’s new Cannabis flower monograph The new monograph Cannabis flower (Cannabis flower, monograph 3028) will be available next year in January 2024 with publication of the supplement 11.5. The monograph will enter into force several months later, in July 2024. 1 July 2024).

Compounding 98

Compounding Pharmaceutical Companies Pharmaceutical Companies 98

European Pharmaceutical Review

NOVEMBER 1, 2024

The worldwide pharmaceutical container packaging market is expected to rise in revenue from $104.12 percent between 2024 and 2033. As pharmaceutical companies are making investments in sustainable packaging this is also driving demand in this market, based on analysis of the study’s findings.

Packaging 52

Packaging Dosage Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

JUNE 10, 2024

Radioligand therapy developments in 2023 and 2024 Other companies making progress producing radioligand therapies include Novartis. In January 2024, the pharmaceutical company obtained manufacturing authorisation for its largest radioligand therapy facility. billion.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

The Guardian - Pharmaceutical Industry

NOVEMBER 12, 2024

Britain’s biggest pharmaceutical company raises 2024 profit forecast and announces $3.5bn US investment Business live – latest updates AstraZeneca has said the drugmaker is taking investigations by Chinese authorities into its business in the country “very seriously” and will “fully cooperate” with them. Continue reading.

Pharmaceutical Companies 57

Pharmaceutical Companies Pharmaceutical Companies 57

European Pharmaceutical Review

JUNE 7, 2024

Pharmaceutical companies ask themselves this question before embracing the latest technologies because every innovation comes with both opportunities and risks. European approach In March 2024, the European Parliament adopted the European AI Act, which is expected to enter into force in May or June 2024. Friend or foe?

Health and Personal Care Stores 113

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies 113

STAT

JULY 10, 2024

… Biopharma layoffs have been higher over the past couple of years than during the industry’s boom times amid the Covid-19 pandemic, and job cuts this year have mainly hit larger pharmaceutical companies to a greater degree than in the past , according to STAT.

Pharmaceutical Companies 113

Pharmaceutical Companies Pharmaceutical Companies 113

Viseven

AUGUST 1, 2024

Because of these changes, pharmaceutical companies are rethinking how they do business. Main Advantages of CRM in the Pharma Industry Current market research shows steady growth in the global pharmaceutical CRM market, confirming the increasing adoption of the solution. each year from 2024 to 2033.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

PharmExec

APRIL 29, 2024

A Frost & Sullivan industry-wide survey reveals which insights most pharmaceutical companies have mastered and which are still painful or impossible to extract and details the complexity of the process, the confidence companies have in their findings, and more.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

JUNE 26, 2024

This is in addition to the company’s current workforce in the region, which totals nearly 2,500 employees, the firm stated. They added that in 2024, it anticipates increasing its actual production investments. This is compared to the company’s $3.9 (DKK This is compared to the company’s $3.9 (DKK

Pharmaceutical Companies 104

Pharmaceutical Companies Pharmaceutical Companies 104

Fierce Pharma

MARCH 28, 2024

[Yangzhou, China - March 26, 2024] - Aurisco Pharmaceutical, a leading global pharmaceutical company, is excited to announce the completion of its investment in cGMP peptide manufacturing capacity | Aurisco Pharmaceutical Launches State-of-the-Art Manufacturing Facility for GLP-1 Peptides

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

Hospital Pharmacy Europe

NOVEMBER 9, 2023

It also allows pharmaceutical companies to monitor product information and keep it constantly updated, as well as offering healthcare professionals and patients greater accessibility. Pharmaceutical companies participating in the pilot create and submit the ePI via the PLM Portal as part of their regulatory application.

Adverse Reactions 97

Adverse Reactions Pharmaceutical Companies Pharmaceutical Companies Hospitals 97

European Pharmaceutical Review

NOVEMBER 13, 2023

The pharmaceutical company also highlighted that the decision was additionally supported by data from a subpopulation of adult patients with moderate to severe anaemia from the SIMPLIFY-1 Phase III trial. GSK shared that a decision on marketing authorisation for momelotinib in the EU is expected by early 2024.

Adverse Reactions 109

Adverse Reactions Pharmaceutical Companies Pharmaceutical Companies 109

European Pharmaceutical Review

APRIL 26, 2024

“approval [of Pyzchiva ® (biosimilar ustekinumab)] of is a crucial step towards offering European patients an additional safe and effective treatment option” Pharmaceutical company Sandoz has announced that the European Commission (EC) has granted marketing authorisation for Pyzchiva ® (biosimilar ustekinumab ).

Packaging 98

Packaging Pharmaceutical Companies Pharmaceutical Companies FDA 98

European Pharmaceutical Review

OCTOBER 26, 2023

Upon MHRA approval, the company plans to initiate a Phase IIa clinical trial to evaluate the multi ascending dose, safety and tolerability of PK051,” stated Dr Bob Smith, Clinical Director at PharmaKure. The first patient is expected to be dosed in early 2024, with clinical data emerging within 12 months of first dose.”

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

European Pharmaceutical Review

SEPTEMBER 21, 2023

The new administration method will be available in the UK for tralokinumab patients from early 2024. Atopic dermatitis This chronic, inflammatory skin disease is characterised by symptoms such as intense itch and eczematous lesions.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Immunization 105

The Guardian - Pharmaceutical Industry

MAY 2, 2024

Novo Nordisk, which is now Europe’s most valuable company, also reports strong sales of diabetes drug Ozempic Strong sales of diabetes and weight loss drugs Ozempic and Wegovy have prompted the Danish pharmaceutical company Novo Nordisk to raise its 2024 profit forecast to up to £15.3bn, with supply shortages starting to ease.

Pharmaceutical Companies 55

Pharmaceutical Companies Pharmaceutical Companies 55

European Pharmaceutical Review

JUNE 4, 2024

A new start at Eli Lilly Melissa Seymour will begin her new role as EVP at Eli Lilly on 22 July 2024. As part of this position, she will also serve as a member of the company’s Executive Committee. ” Previous roles Seymour has held various senior leadership roles at global pharmaceutical companies. .”

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

AUGUST 7, 2024

Cheryl Barton Mike.Hammerton Wed, 07/08/2024 - 10:51 Cheryl Barton Dr Cheryl L Barton is an independent consultant with over 20 years' research and business analysis experience.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

European Pharmaceutical Review

AUGUST 9, 2023

The pharmaceutical company announced that it plans to submit to global health authorities in 2024. In post-hoc analyses from pivotal Phase III registration studies, Xolair demonstrated a 78 percent improvement in quality of life for patients. There were 470 participants in the REMIX-1 study.

Immunization 94

Immunization Pharmaceutical Companies Pharmaceutical Companies 94

European Pharmaceutical Review

JANUARY 25, 2024

Eli Lilly and Company’s Executive Vice President of Global Quality, Johna Norton, is ending her lengthy tenure with the company this summer and retiring after 34 years of service. However, she will continue in her current role and remain as part of Eli Lilly’s Executive Committee of until 31 July 2024.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

European Pharmaceutical Review

JANUARY 8, 2024

Ensuring adequate supply of radioligand therapy According to a statement by Novartis, with supply of Pluvicto unconstrained, the pharmaceutical company has doubled weekly production of the medicine. The new site and Novartis’ New Jersey location will supply the growing demand for US patients and later, in Canada.

FDA 96

FDA Pharmaceutical Companies Pharmaceutical Companies 96

The Checkup by Singlecare

MARCH 8, 2024

The pharmaceutical company that makes Amjevita is called Amgen, Inc. The pharmaceutical company that makes Cyltezo is called Boehringer Ingelheim Pharmaceuticals, Inc. The pharmaceutical company that makes Hyrimoz is called Cordavis Limited. Cyltezo is citrate-free.

Dosage 97

Dosage Pharmaceutical Companies Pharmaceutical Companies FDA 97

ISPE

AUGUST 30, 2023

WuXi Biologics has almost 600 global partners, including all the top 20 pharmaceutical companies. Further works are also in the pipeline including ISO accordion in 2023/2024. Nominate Your Facility for the 2024 Foya Program! Register Now! Applications must be submitted by 4 December 2023.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

MAY 30, 2023

Biotechnology company BioSenic’s affiliate Medsenic has amended its licence agreement with Australia-based pharmaceutical company Phebra for the oral formulation of arsenic trioxide (OATO). The licence agreement is contingent upon Medsenic’s ability to initiate a clinical study before 31 May 2024.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA 52